世界のチプラナビル市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tipranavir Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6043
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、88ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、チプラナビルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口液剤、カプセル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・チプラナビルの市場動向
・企業の競争状況、市場シェア
・チプラナビルの種類別市場規模と予測2016-2027（経口液剤、カプセル）
・チプラナビルの用途別市場規模と予測2016-2027（病院、ドラッグストア）
・チプラナビルの北米市場規模2016-2027（アメリカ、カナダ）
・チプラナビルの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・チプラナビルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・チプラナビルの中南米市場規模2016-2027（メキシコ、ブラジル）
・チプラナビルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boehringer Ingelheim）
・結論

Tipranavir (TPV), or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection.

Market Analysis and Insights: Global Tipranavir Market
The global Tipranavir market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tipranavir market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tipranavir market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tipranavir market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tipranavir market.

Global Tipranavir Scope and Market Size
Tipranavir market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tipranavir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral solution
Capsule

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tipranavir Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral solution
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Tipranavir Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tipranavir Market Perspective (2016-2027)
2.2 Tipranavir Growth Trends by Regions
2.2.1 Tipranavir Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tipranavir Historic Market Share by Regions (2016-2021)
2.2.3 Tipranavir Forecasted Market Size by Regions (2022-2027)
2.3 Tipranavir Industry Dynamic
2.3.1 Tipranavir Market Trends
2.3.2 Tipranavir Market Drivers
2.3.3 Tipranavir Market Challenges
2.3.4 Tipranavir Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tipranavir Players by Revenue
3.1.1 Global Top Tipranavir Players by Revenue (2016-2021)
3.1.2 Global Tipranavir Revenue Market Share by Players (2016-2021)
3.2 Global Tipranavir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tipranavir Revenue
3.4 Global Tipranavir Market Concentration Ratio
3.4.1 Global Tipranavir Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tipranavir Revenue in 2020
3.5 Tipranavir Key Players Head office and Area Served
3.6 Key Players Tipranavir Product Solution and Service
3.7 Date of Enter into Tipranavir Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tipranavir Breakdown Data by Type
4.1 Global Tipranavir Historic Market Size by Type (2016-2021)
4.2 Global Tipranavir Forecasted Market Size by Type (2022-2027)

5 Tipranavir Breakdown Data by Application
5.1 Global Tipranavir Historic Market Size by Application (2016-2021)
5.2 Global Tipranavir Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tipranavir Market Size (2016-2027)
6.2 North America Tipranavir Market Size by Type
6.2.1 North America Tipranavir Market Size by Type (2016-2021)
6.2.2 North America Tipranavir Market Size by Type (2022-2027)
6.2.3 North America Tipranavir Market Size by Type (2016-2027)
6.3 North America Tipranavir Market Size by Application
6.3.1 North America Tipranavir Market Size by Application (2016-2021)
6.3.2 North America Tipranavir Market Size by Application (2022-2027)
6.3.3 North America Tipranavir Market Size by Application (2016-2027)
6.4 North America Tipranavir Market Size by Country
6.4.1 North America Tipranavir Market Size by Country (2016-2021)
6.4.2 North America Tipranavir Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tipranavir Market Size (2016-2027)
7.2 Europe Tipranavir Market Size by Type
7.2.1 Europe Tipranavir Market Size by Type (2016-2021)
7.2.2 Europe Tipranavir Market Size by Type (2022-2027)
7.2.3 Europe Tipranavir Market Size by Type (2016-2027)
7.3 Europe Tipranavir Market Size by Application
7.3.1 Europe Tipranavir Market Size by Application (2016-2021)
7.3.2 Europe Tipranavir Market Size by Application (2022-2027)
7.3.3 Europe Tipranavir Market Size by Application (2016-2027)
7.4 Europe Tipranavir Market Size by Country
7.4.1 Europe Tipranavir Market Size by Country (2016-2021)
7.4.2 Europe Tipranavir Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tipranavir Market Size (2016-2027)
8.2 Asia-Pacific Tipranavir Market Size by Type
8.2.1 Asia-Pacific Tipranavir Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tipranavir Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tipranavir Market Size by Type (2016-2027)
8.3 Asia-Pacific Tipranavir Market Size by Application
8.3.1 Asia-Pacific Tipranavir Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tipranavir Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tipranavir Market Size by Application (2016-2027)
8.4 Asia-Pacific Tipranavir Market Size by Region
8.4.1 Asia-Pacific Tipranavir Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tipranavir Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tipranavir Market Size (2016-2027)
9.2 Latin America Tipranavir Market Size by Type
9.2.1 Latin America Tipranavir Market Size by Type (2016-2021)
9.2.2 Latin America Tipranavir Market Size by Type (2022-2027)
9.2.3 Latin America Tipranavir Market Size by Type (2016-2027)
9.3 Latin America Tipranavir Market Size by Application
9.3.1 Latin America Tipranavir Market Size by Application (2016-2021)
9.3.2 Latin America Tipranavir Market Size by Application (2022-2027)
9.3.3 Latin America Tipranavir Market Size by Application (2016-2027)
9.4 Latin America Tipranavir Market Size by Country
9.4.1 Latin America Tipranavir Market Size by Country (2016-2021)
9.4.2 Latin America Tipranavir Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tipranavir Market Size (2016-2027)
10.2 Middle East & Africa Tipranavir Market Size by Type
10.2.1 Middle East & Africa Tipranavir Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tipranavir Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tipranavir Market Size by Type (2016-2027)
10.3 Middle East & Africa Tipranavir Market Size by Application
10.3.1 Middle East & Africa Tipranavir Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tipranavir Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tipranavir Market Size by Application (2016-2027)
10.4 Middle East & Africa Tipranavir Market Size by Country
10.4.1 Middle East & Africa Tipranavir Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tipranavir Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Tipranavir Introduction
11.1.4 Boehringer Ingelheim Revenue in Tipranavir Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tipranavir Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral solution
Table 3. Key Players of Capsule
Table 4. Global Tipranavir Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Tipranavir Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tipranavir Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Tipranavir Market Share by Regions (2016-2021)
Table 8. Global Tipranavir Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Tipranavir Market Share by Regions (2022-2027)
Table 10. Tipranavir Market Trends
Table 11. Tipranavir Market Drivers
Table 12. Tipranavir Market Challenges
Table 13. Tipranavir Market Restraints
Table 14. Global Tipranavir Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Tipranavir Market Share by Players (2016-2021)
Table 16. Global Top Tipranavir Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tipranavir as of 2020)
Table 17. Ranking of Global Top Tipranavir Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Tipranavir Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tipranavir Product Solution and Service
Table 21. Date of Enter into Tipranavir Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tipranavir Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Tipranavir Revenue Market Share by Type (2016-2021)
Table 25. Global Tipranavir Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Tipranavir Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Tipranavir Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Tipranavir Revenue Market Share by Application (2016-2021)
Table 29. Global Tipranavir Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Tipranavir Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Tipranavir Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Tipranavir Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Tipranavir Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Tipranavir Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Tipranavir Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Tipranavir Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Tipranavir Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Tipranavir Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Tipranavir Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Tipranavir Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Tipranavir Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Tipranavir Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Tipranavir Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Tipranavir Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tipranavir Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tipranavir Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tipranavir Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Tipranavir Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Tipranavir Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Tipranavir Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Tipranavir Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Tipranavir Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Tipranavir Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Tipranavir Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Tipranavir Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Tipranavir Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tipranavir Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tipranavir Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tipranavir Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Tipranavir Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boehringer Ingelheim Company Details
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Tipranavir Product
Table 64. Boehringer Ingelheim Revenue in Tipranavir Business (2016-2021) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tipranavir Market Share by Type: 2020 VS 2027
Figure 2. Oral solution Features
Figure 3. Capsule Features
Figure 4. Global Tipranavir Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Tipranavir Report Years Considered
Figure 8. Global Tipranavir Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Tipranavir Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tipranavir Market Share by Regions: 2020 VS 2027
Figure 11. Global Tipranavir Market Share by Regions (2022-2027)
Figure 12. Global Tipranavir Market Share by Players in 2020
Figure 13. Global Top Tipranavir Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tipranavir as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Tipranavir Revenue in 2020
Figure 15. Global Tipranavir Revenue Market Share by Type (2016-2021)
Figure 16. Global Tipranavir Revenue Market Share by Type (2022-2027)
Figure 17. North America Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Tipranavir Market Share by Type (2016-2027)
Figure 19. North America Tipranavir Market Share by Application (2016-2027)
Figure 20. North America Tipranavir Market Share by Country (2016-2027)
Figure 21. United States Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Tipranavir Market Share by Type (2016-2027)
Figure 25. Europe Tipranavir Market Share by Application (2016-2027)
Figure 26. Europe Tipranavir Market Share by Country (2016-2027)
Figure 27. Germany Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Tipranavir Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Tipranavir Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Tipranavir Market Share by Region (2016-2027)
Figure 37. China Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Tipranavir Market Share by Type (2016-2027)
Figure 45. Latin America Tipranavir Market Share by Application (2016-2027)
Figure 46. Latin America Tipranavir Market Share by Country (2016-2027)
Figure 47. Mexico Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Tipranavir Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Tipranavir Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Tipranavir Market Share by Country (2016-2027)
Figure 53. Turkey Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Tipranavir Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Tipranavir Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

以下、関連資料のご紹介

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のイクサベピロン市場規模・現状・予測（2021年-2027年）

Global Ixabepilone Market Size, Status and Forecast 2021-2027
QFJ1-5813 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、イクサベピロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（15MG/VIAL、45MG/VIAL）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のアリスキレン市場規模・現状・予測（2021年-2027年）

Global Aliskiren Market Size, Status and Forecast 2021-2027
QFJ1-5571 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アリスキレンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（150mg錠、300mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
世界のシクロベンザプリン医薬品市場規模・現状・予測（2021年-2027年） Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…
世界の大麻薬市場規模・現状・予測（2021年-2027年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020,…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
世界のセレコキシブカプセル市場規模・現状・予測（2021年-2027年） Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheuma…